Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma Says Receives ANVISA Approval To Manufacture And Market Semaglutide In Brazil

BRIEF-Sun Pharma Says Receives ANVISA Approval To Manufacture And Market Semaglutide In Brazil

- Sun Pharmaceutical Industries Ltd SUN.NS:

  • SUN PHARMA - PHARMA RECEIVES ANVISA APPROVAL TO MANUFACTURE AND MARKET SEMAGLUTIDE IN BRAZIL

  • SUN PHARMA - PHARMA TO LAUNCH SEMAGLUTIDE IN BRAZIL WITH HYPERA PHARMA

  • SUN PHARMA - SEMAGLUTIDE TO BE AVAILABLE IN 2 MG/1.5 ML AND 4 MG/3 ML STRENGTHS

Source text: ID:nNSE6hJ79b

Further company coverage: SUN.NS


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news